ECHDC1 Human

Enoyl CoA Hydratase Domain Containing 1 Human Recombinant
Cat. No.
BT25699
Source
E.coli.
Synonyms
Ethylmalonyl-CoA decarboxylase, Enoyl-CoA hydratase domain-containing protein 1, Methylmalonyl-CoA decarboxylase, MMCD, ECHDC1, dJ351K20.2.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

SNAP25 Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 226 amino acids (1-206 a.a.) and having a molecular mass of 25.4 kDa.
SNAP25 is fused to a 20 amino acid His Tag at N-terminus and purified by conventional chromatography techniques.

Product Specs

Introduction
Enoyl CoA hydratase domain containing 1 (ECHDC1), a member of the enoyl-CoA hydratase/isomerase family, is an enzyme that hydrates the double bond between the second and third carbons on acyl-CoA. This enzyme plays a crucial role in fatty acid metabolism, facilitating the production of both acetyl CoA and energy.
Description
Recombinant Human ECHDC1, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein comprises 226 amino acids (specifically, amino acids 1 to 206), resulting in a molecular mass of 25.4 kDa. Notably, a 20 amino acid His Tag is fused to the N-terminus of ECHDC1. The purification process involves conventional chromatography techniques.
Physical Appearance
The product is a sterile, filtered solution that is colorless.
Formulation
The ECHDC1 solution is provided at a concentration of 1mg/ml. The solution is buffered with 20mM Tris-HCl at a pH of 8.0. Additionally, it contains 10% glycerol, 1mM DTT, and 0.1M NaCl.
Stability
For short-term storage (2-4 weeks), the ECHDC1 solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. Adding a carrier protein like 0.1% HSA or BSA is advisable for long-term storage. Repeated freezing and thawing of the solution should be avoided.
Purity
Analysis by SDS-PAGE indicates a purity greater than 95%.
Synonyms
Ethylmalonyl-CoA decarboxylase, Enoyl-CoA hydratase domain-containing protein 1, Methylmalonyl-CoA decarboxylase, MMCD, ECHDC1, dJ351K20.2.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MALKQEMAKS LLKTASLSGR TKLLHQTGLS LYSTSHGFYE EEVKKTLQQF PGGSIDLQKE DNGIGILTLN NPSRMNAFSG VMMLQLLEKV IELENWTEGK GLIVRGAKNT FSSGSDLNAV KSLGTPEDGM AVCMFMQNTL TRFMRLPLIS VALVQGWALG
GGAEFTTACD FRLMTPESKI RFVHKEMGII PSWGGTTRLV EIIGSRQALK VLSGALKLDS KNALNIGMVE EVLQSSDETK SLEEAQEWLK QFIQGPPEVI RALKKSVCSG RELYLEEALQ NERDLLGTVW GGPANLEAIA KKGKFNK.

Product Science Overview

Gene and Protein Structure

The ECHDC1 gene is located on chromosome 19 and encodes a protein that is primarily found in the cytosol . The protein contains a conserved domain characteristic of enoyl-CoA hydratases, which are enzymes involved in the hydration of enoyl-CoA to 3-hydroxyacyl-CoA during fatty acid metabolism .

Biological Function

ECHDC1 functions as a metabolite repair enzyme. It decarboxylates ethylmalonyl-CoA or methylmalonyl-CoA, which are by-products of acetyl-CoA carboxylase activity. This prevents these by-products from being used to synthesize branched-chain fatty acids, thus maintaining the efficiency of fatty acid metabolism .

Localization and Expression

The ECHDC1 protein contains a C-terminal peroxisomal targeting sequence, which allows it to localize to the peroxisome . This localization is essential for its role in the auxiliary step of the fatty acid beta-oxidation pathway. The protein is expressed in various tissues, with higher expression levels observed in metabolically active tissues .

Clinical Significance

Mutations in the ECHDC1 gene can lead to metabolic disorders. For instance, short-chain enoyl-CoA hydratase (SCEH) deficiency is a rare congenital metabolic disorder caused by biallelic mutations in the ECHS1 gene, which is closely related to ECHDC1 . Clinical manifestations of this deficiency include severe developmental delay, regression, dystonia, seizures, and elevated lactate levels .

Research and Applications

Recombinant human ECHDC1 is used in research to study its role in fatty acid metabolism and its potential implications in metabolic disorders. Understanding the function and regulation of ECHDC1 can provide insights into the development of therapeutic strategies for metabolic diseases.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.